Benjamin Stecher – författare
Visar alla böcker från författaren Benjamin Stecher. Handla med fri frakt och snabb leverans.
2 produkter
2 produkter
Brain Fables
The Hidden History of Neurodegenerative Diseases and a Blueprint to Conquer Them
Häftad, Engelska, 2020
252 kr
Skickas inom 7-10 vardagar
An estimated 80 million people live with a neurodegenerative disease. That number is expected to increase rapidly as populations age, lifespans increase, and exposure to toxins rises. Despite decades of research and billions in funding, there are no medications that can slow, much less stop, the progress of these diseases. This is because diseases such as Parkinson's and Alzheimer's do not exist in biology. Yet, hundreds of clinical trials around the world are examining the potential of single therapies in thousands of people sharing one of these labels. Compounding the problem, these therapies were developed on evidence from models that do not come close to capturing the complexity of these diseases in the affected humans. These practices must end. Brain Fables is a call to refocus on understanding living and aging to create the personalized treatments each affected individual desperately needs.
Reprogramming the Brain
A Guide to the Future of the Brain and Neuromodulation by a Patient and his Doctor
Häftad, Engelska, 2024
237 kr
Skickas inom 5-8 vardagar
In June 2021, Doctor and Patient decided that time had come to surgically implant two six-inch-long metal alloy spikes all the way through Ben’s brain. It was felt that the medications Ben was taking to control his Parkinson’s disease had become unmanageable. Back then, Ben was taking about 20 different pills a day. Each pill, if it absorbed properly, would activate the dopamine pathways in his brain and induce uncontrollable writhing movements that would last for about an hour. He would then get about 20 minutes where he’d feel somewhat normal before the slowness and tremor kicked in again. So, he’d take another pill and the cycle would repeat.After months of adjusting his medication and finding just the right settings on his deep brain stimulator, it was decided, for the first time ever in a clinical trial in North America, to flip on the adaptive settings.This is the story of how that decision was made and what happened next.